PART 3 / CH 54
Mood Stabilizer Tips
Marion Eakin and George Papakostas
Checking blood levels
· Lab work is required for lithium, valproic acid, carbamazapine
· Levels of lithium, valproic acid, carbamazapine should be drawn at trough, i.e. ~ 11-12 hours post last dose and prior to next dose.
· Have patients delay their a.m. dose until after blood is drawn.
· After a dose change, allow 3-5 days to reach steady state (depends on t ½)
Drug interactions and toxicity
· Carbamazapine has many drug-drug interactions, check PDR before prescribing
· Avoid combination of carbamazapine + clozapine (Clozaril): increased risk of agranulocytosis
· 1-3/1000 patients develop a potentially life-threatening rash on lamotrigine (Stevens-Johnson, toxic epidermal necrolysis etc.)
· Valproic acid will increase level and half-life of lamotrigine by 2, increasing risk of life-threatening rash associated with lamotrigine.
Lamotrigine and Gabapentin
Marion Eakin and George Papakostas
| Gabapentin | Lamotrigine | |
|---|---|---|
| Start | 300QD | 25 QD; titrate slowly |
| Clearance | Renal (unaltered) | Hepatic>renal (unaltered) |
| Side effects | Somnolence, ataxia, fatigue, dizziness, nystagmus | RASH! Dizziness, ataxia, sedation, nause, visual blurring, headache |
| Toxicity | Diarrhea, lethargy, ataxia, labored breathing, diplopia | Dizziness, headache, somnolence, coma |
| Labs | None required | None required; lytes/BUN/Cr and LFT in older patients |
| Target | N/A | N/A |
| Teratogen | + | ? |